Bg pattern

DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Desloratadine Viatris 5 mg Film-Coated Tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Desloratadine Viatris and what is it used for
  2. What you need to know before you take Desloratadine Viatris
  3. How to take Desloratadine Viatris
  4. Possible side effects
  5. Storage of Desloratadine Viatris
  6. Contents of the pack and further information

1. What is Desloratadine Viatris and what is it used for

Desloratadine Viatris is a non-drowsy antihistamine medicine that helps to control allergic reactions and their symptoms.

Desloratadine is indicated in adults and adolescents (12 years of age and older) to relieve the symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, such as hay fever or house dust mite allergy). These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red, or watery eyes.

Desloratadine is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives.

Relief of these symptoms lasts a full day and helps you to carry out your daily activities and sleep.

You should consult a doctor if your symptoms worsen or do not improve.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Desloratadine Viatris

Do not take Desloratadine Viatris

  • If you are allergic to desloratadine, to any of the other ingredients of this medicine (listed in section 6), or to loratadine.

Warnings and precautions

Consult your doctor or pharmacist before taking Desloratadine Viatris if:

  • You have a history of, or have had, seizures.
  • You have kidney problems.

If you are not sure if any of these apply to you, ask your doctor or pharmacist.

Children

Desloratadine tablets are not suitable for children under 12 years of age.

Other medicines and Desloratadine Viatris

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Taking Desloratadine Viatris with alcohol

Be careful when taking desloratadine with alcohol.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Desloratadine Viatris is not recommended if you are pregnant or breastfeeding.

Driving and using machines

At the recommended dose, desloratadine is not expected to cause drowsiness or affect your ability to drive or use machines. However, in rare cases, some people may experience drowsiness, which may affect their ability to drive or use machines.

Desloratadine Viatris contains sunset yellow FCF (E110) and sodium

Sunset yellow FCF (E 110) may cause allergic reactions.

This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet, which is essentially "sodium-free".

3. How to take Desloratadine Viatris

Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.

The recommended dose for adults and adolescents (12 years of age and older) is one tablet once a day.

Swallow the tablet whole with a glass of water, with or without food.

Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you have and how long you should take desloratadine.

If your allergic rhinitis is intermittent (symptoms present for less than 4 days a week or for less than 4 weeks), your doctor will recommend a treatment plan based on the evaluation of your medical history.

If your allergic rhinitis is persistent (symptoms present for 4 or more days a week and for more than 4 weeks), your doctor may recommend long-term treatment.

For urticaria, the duration of treatment may vary from one patient to another, and you should follow your doctor's instructions.

If you take more Desloratadine Viatris than you should

Take desloratadine only as your doctor has told you. An accidental overdose is not expected to cause serious problems.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Desloratadine Viatris

If you forget to take your dose at the scheduled time, take it as soon as possible and then continue with your regular dosing schedule. Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. In adults, side effects were approximately the same as with a placebo tablet. However, fatigue, dry mouth, and headache were reported more frequently with desloratadine than with the placebo tablet. In adolescents, headache was the most frequently reported side effect.

If you experience any of the following side effects, stop taking this medicine and contact your doctor or go to the emergency department of your nearest hospital immediately:

Very rare (may affect up to 1 in 10,000 people):

  • Severe allergic reactions such as difficulty breathing, shortness of breath, wheezing, itching, rash, and swelling of the face, lips, tongue, or other parts of the body, and skin rash.
  • Seizures (convulsions).
  • Liver disease (nausea, vomiting, loss of appetite, feeling unwell, fever, itching, yellowing of the skin and eyes, pale stools, dark urine).

Frequency not known (cannot be estimated from the available data):

  • Changes in heart rhythm, which may cause dizziness or weakness. This can be detected in tests to check the electrical activity of the heart (electrocardiogram or ECG).

In clinical trials with desloratadine, the following side effects were reported as:

Frequent (may affect up to 1 in 10 people):

  • Fatigue.
  • Dry mouth.
  • Headache.

During the marketing of desloratadine, the following side effects were reported in adults as:

Very rare (may affect up to 1 in 10,000 people):

  • Fast heart rate.
  • Nausea (feeling sick).
  • Dizziness.
  • Muscle pain.
  • Agitation with increased body movement.
  • Stomach pain.
  • Upset stomach.
  • Drowsiness.
  • Seeing, feeling, or hearing things that are not there (hallucinations).
  • Strong or irregular heartbeats.
  • Feeling sick (nausea).
  • Diarrhea.
  • Difficulty sleeping.
  • Abnormal liver function tests.

Frequency not known (cannot be estimated from the available data):

  • Abnormal behavior.
  • Aggression.
  • Unusual weakness.
  • Increased sensitivity of the skin to the sun, even on cloudy days, and to ultraviolet light, such as that from a sunlamp.
  • Weight gain, increased appetite.
  • Depressed mood.
  • Dry eyes.

Other side effects in children and adolescents

Frequency not known (cannot be estimated from the available data):

  • Slow heart rate.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Desloratadine Viatris

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the carton, blister, and bottle after EXP. The expiry date refers to the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Desloratadine Viatris

The active substance is desloratadine. Each tablet contains 5 mg of desloratadine.

The other ingredients are: magnesium stearate (E 572), sodium lauryl sulfate (E 487), anhydrous colloidal silica (E 551), microcrystalline cellulose (E 460i), and pregelatinized corn starch.

The tablet coating contains: polyvinyl alcohol (E 1203), carmine indigo aluminum lake (E 132), sunset yellow FCF aluminum lake (E 110), macrogol, talc (E 553b), and titanium dioxide (E 171).

See section 2, "Desloratadine Viatris contains sunset yellow FCF (E110) and sodium".

Appearance of the product and pack contents

Desloratadine Viatris are blue, round, curved-sided tablets marked with "DE 5" on one side and an "M" on the other.

Desloratadine Viatris 5 mg film-coated tablets are packaged in blisters containing 10, 15, 20, 30, 50, 60, 90, 100 tablets or in bottles containing 30 and 250 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Viatris Limited

Damastown Industrial Park

Mulhuddart, Dublin 15

Dublin

Ireland

Manufacturer:

McDermott Laboratories Limited t/a Gerard Laboratories

35/36 Baldoyle Industrial Estate

Grange Road, Dublin 13

Ireland

or

VIATRIS SANTE

360 Avenue Henri Schneider

69300 Meyzieu

France

or

Mylan Hungary Kft. / Mylan Hungary Ltd.

Mylan utca 1

Komárom, 2900

Hungary

You can request more information about this medicine from the local representative of the marketing authorization holder:

Viatris Pharmaceuticals, S.L.U.

C/ General Aranaz, 86

28027 - Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

SpainDesloratadine Viatris 5 mg film-coated tablets EFG

FranceDesloratadine Viatris 5 mg, film-coated tablet

ItalyDesloratadine Mylan Generics

NetherlandsDesloratadine Viatris 5 mg, film-coated tablets

United Kingdom (Northern Ireland)Desloratadine Mylan 5mg Film-coated Tablets

Czech RepublicDesloratadine Viatris 5mg, film-coated tablets

SwedenDesloratadine Viatris 5 mg film-coated tablet

Date of last revision of this leaflet:July 2025

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) https://www.aemps.gob.es/

  • Country of registration
  • Average pharmacy price
    6.63 EUR
  • Availability in pharmacies
    Supply issue reported
    Data from the Spanish Agency of Medicines (AEMPS) indicates a supply issue affecting this medicine.<br><br>Availability may be limited in some pharmacies.<br><br>For updates or alternatives, consult your pharmacist.
  • Active substance
  • Prescription required
    Yes
  • Manufacturer
  • Alternatives to DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS
    Dosage form:  ORAL SOLUTION/SUSPENSION, 0.5 mg
    Active substance:  desloratadine
    Manufacturer:  Organon N.V.
    Prescription required
    Dosage form:  ORALLY DISINTEGRATING TABLET/LIOTAB, 5 mg
    Active substance:  desloratadine
    Manufacturer:  Organon N.V.
    Prescription required
    Dosage form:  TABLET, 5 mg
    Active substance:  desloratadine
    Manufacturer:  Organon N.V.
    Prescription required

Online doctors for DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS

Discuss questions about DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS?
DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS?
The active ingredient in DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS is desloratadine. This information helps identify medicines with the same composition but different brand names.
How much does DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS is around 6.63 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS?
DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS is manufactured by Viatris Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS?
Other medicines with the same active substance (desloratadine) include AERIUS 0.5 mg/ml ORAL SOLUTION, AERIUS 5 mg ORALLY DISINTEGRATING TABLETS, AERIUS 5 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media